In real‐world data from 524 patients who received ruxolitinib for myelofibrosis, the incidence of and risk factors associated with drug discontinuation are investigated along with how reasons for dis…
This phase 1 trial evaluated the safety, toxicity, and preliminary antitumor activity of intraperitoneal paclitaxel for patients with gastric cancer metastatic to the peritoneum. Paclitaxel…
Knowledge about the JAK2 V617F mutation has made many advances in recent years, and this review provides an overview of how the JAK2 V617F mutation…
The field of melanoma therapeutics is moving quickly with the first approval of adoptive cell transfer in solid tumors. Moreover, individualized neoantigen therapies, PRAME-targeting strategies,…
The field of melanoma therapeutics is moving quickly with the first approval of adoptive cell transfer in solid tumors. Moreover, individualized neoantigen therapies, PRAME-targeting strategies,…
Akseli Hemminki (Helsinki, Finland) John B. Haanen (Amsterdam, Netherlands) Anna M. Di Giacomo (Siena, Italy) Chongren Wang (Shanghai, China) OVV-01 is a genetically engineered VSV…
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
Approximately 32% of human epidermal growth factor receptor 2 (HER2)-negative breast cancer in an international multicenter cohort of 3547 women ≤40 years old with germline…
The field of melanoma therapeutics is moving quickly with the first approval of adoptive cell transfer in solid tumors. Moreover, individualized neoantigen therapies, PRAME-targeting strategies,…
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
